

( (S (NP-SBJ The Food and Drug Administration)
     (VP said
         (SBAR 0
               (S (NP-SBJ-3 American Home Products Corp.)
                  (VP agreed
                      (S (NP-SBJ *-3)
                         (VP to
                             (VP recall
                                 (NP (NP certain generic drugs)
                                     (SBAR (WHNP-2 that)
                                           (S (NP-SBJ-1 *T*-2)
                                              (VP were
                                                  (VP produced
                                                      (NP *-1)
                                                      (PP by
                                                          (NP-LGS (NP its Quantum Pharmics unit)
								  (PP-LOC in
									  (NP (NP Amityville)
									      ,
									      (NP N.Y)))))))))))))))))
     .))
( (S (NP-SBJ Quantum)
     (VP stopped
         (VP shipping
             (NP the drugs)
	     (NP-TMP last month)
	     ,
	     (PP-TMP following
		     (NP (NP a federal investigation)
			 (VP regarding
			     (NP (NP information)
				 (SBAR (WHNP-1 0)
				       (S (NP-SBJ-2 the company)
					  (VP supplied
					      (NP *T*-1)
					      (S-PRP (NP-SBJ *-2)
						     (VP to
							 (VP obtain
							     (NP three drug approvals)))))))))))))
     .))
( (S (NP-SBJ The FDA)
     (VP requested
         (NP (NP the recall)
             (PP of
                 (NP (NP Quantum 's)
                     mioxidil tablets , chlorazepate dipotassium tablets and meclofenamate sodium capsules)))
         (SBAR-PRP because
		   (PRN ,
			(S (NP-SBJ it)
			   (VP said
			       (SBAR 0
				     (S *T*-2))))
			,)
		   (S-2 (NP-SBJ-1 (NP the size)
				  (PP of
				      (NP (NP the production runs)
					  (VP submitted
					      (NP *)
					      (PP-PRP for
						      (NP testing))
					      (S-PRP (NP-SBJ *)
						     (VP to
							 (VP gain
							     (NP FDA approval))))))))
			(VP was
			    (PP-LOC in
				    (NP each case))
			    (VP misrepresented
				(NP *-1)
				(PP-CLR as
					(ADJP (ADJP much larger)
					      (SBAR than
						    (S (NP-SBJ it)
						       (ADVP actually)
						       (VP was
							   (ADJP-PRD *?*)))))))))))
     .))
( (S (NP-SBJ-1 (NP American Home Products)
	       ,
	       (VP based
		   (NP *)
		   (PP-LOC-CLR in
			       (NP New York)))
	       ,)
     (VP agreed
         (S (NP-SBJ *-1)
            (VP to
                (VP recall
                    (NP (NP four other products)
                        ,
                        (NP trazadone
                            ,
                            doxepin
                            ,
                            diazepam
                            and
                            lorazapam))
                    ,
                    (PP-PRP because of
			    (NP (NP concerns)
				(PP about
				    (NP (NP data)
					(VP submitted
					    (NP *)
					    (PP-LOC in
						    (NP their original approval applications))
					    (PP-LOC before
						    (NP the FDA)))))))))))
     .))
( (S (S-TPC-2 (NP-SBJ-1 (NP No safety problems)
			(PP with
			    (NP the products)))
	      (VP are
		  (VP known
		      (NP *-1))))
     ,
     (NP-SBJ the FDA)
     (VP said
	 (SBAR 0
	       (S *T*-2)))
     .))
( (S (NP-SBJ An FDA spokesperson)
     (VP said
         (SBAR 0
               (S (NP-SBJ the drugs)
                  (VP are
                      (ADVP-TMP still)
                      (ADJP-PRD available)
		      (PP-LOC under
			      (NP other brand names))))))
     .))
( (S (NP-TMP Last month)
     ,
     (NP-SBJ American Home Products)
     (VP said
         (SBAR 0
               (S (NP-SBJ it)
                  (VP was
                      (VP suspending
                          (NP (NP production and distribution)
                              (PP of
                                  (NP (NP all 21)
                                      (PP of
                                          (NP (NP Quantum 's)
                                              generic drug products)))))
			  (PP pending
			      (NP (NP the completion)
				  (PP of
				      (NP an exhaustive internal audit)))))))))
     .))
( (S (NP-SBJ It)
     (ADVP also)
     (ADVP-TMP temporarily)
     (VP closed
         (NP Quantum)
	 ,
	 (PP-PRP because of
		 (NP (NP the internal investigation)
		     , 
		     as well as
		     (NP (NP the FDA 's)
			 ongoing inquiry))))
     .))
( (S (PP-LOC In
	     (NP New York Stock Exchange composite trading))
     ,
     (NP-SBJ American Home Products)
     (VP rose
         (NP-EXT 75 cents)
         (PP-DIR to
		 (NP $ 105 *U*))
         (PP-TMP on
		 (NP Friday)))
     .))
